Bioactive Wound Care Market accounted 20.7 billion USD in 2020 and is expected to grow with a CAGR of 4.40% approximately during the forecast period.  Bioactive wound care products are produced from natural and artificial sources and act as substitutes for traditional wound healing products. The conventional wound healing products are less effective when compared to the bioactive wound care products. The bioactive wound care products minimise the time taken for wound healing and are also cost effective. The market consists of a broad range of wound dressings which are known for their biodegradable properties and the capacity to combat microbial infections. They also have anti-biotic properties that helps in healing and controlling infections. 

Market Segmentation:

On the basis of product type, the bioactive wound care market can be classified into alginate dressings, antimicrobial dressings, hydrocolloid dressings, and others. Based on wound type, the market is segmented into surgical wounds, ulcers, gunshot wounds, traumatic wounds, burns, and others. According to end-users, the bioactive wound care market can be categorised into hospitals, ambulatory surgical centres, trauma centres, armed forces, pharmacy stores, and others. Geographically, the global market can be broadly divided into five regions mainly North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Dynamics and Factors:

The rising population suffering from chronic disorders such as diabetes and cancer is a key driver for the bioactive wound care market across the globe. For instance, according to the International Diabetes Federation, nearly 382 million people were suffering from diabetes in 2013 and the number is expected to reach 592 million by 2035. This huge diabetic population would also suffer from various complications such as diabetic foot ulcers, pressure sores, diabetic neuropathy, and peripheral vascular neuropathy. These complications are anticipated to propel the demand for bioactive wound care products. Additionally, increasing awareness towards efficient and less time-consuming healthcare treatments among the population and growing disposable income is further augmenting the demand for bioactive wound care products. However, high cost associated with the R&D of bioactive care products and availability of substitute wound care products are major factors restraining the growth of the market. Moreover, rising number of tissue replacement procedures and growing awareness amongst healthcare professionals regarding effective wound care management would further boost the market growth in the coming future.  

Geographic Analysis:

North America is expected to dominate the global bioactive wound care market during the forecast period in terms of market share. Most of the population is suffering from several acute and chronic infections which is the major factor for the high market share. For instance, chronic wounds affect over 5.7 million patients in the U.S. alone and are projected to cost around 20 billion USD annually, thus accelerating the market growth in the region. Europe is the second-most dominating market. The market growth is getting highly sophisticated healthcare infrastructure, the patient population with high awareness of bioactive wound care. Asia Pacific region is predicted to be the fastest-growing market during the forecast period in terms of market share. The growing awareness of available treatment options and the growing geriatric population are the major factors driving the market growth. Favourable government initiatives and improved healthcare infrastructure are further augmenting the market growth in the APAC region. Latin America is expected to witness sluggish growth in the bioactive wound care market during the forecast period. The growing incidence of several disease-related infections and the high prevalence of surgical infections are major factors driving the bioactive wound care market in the Latin American region.    

Competitive Scenario:

The key players operating in the global market are –

3M Healthcare Ltd., Smith & Nephew Plc, Covalon Technologies Ltd, Paul Hartmann AG, Derma Sciences, Medtronic, Medline Industries Inc., ConvaTec, Molnlycke Healthcare, Organogenesis Inc.

Bioactive Wound Care Market Report Scope